Nippon India Pharma Fund vs Quant Healthcare Fund Regular compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8114 Cr | ₹402 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹1000 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 17 Jun 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare TRI |
| Turn Over | 21% | % |
| Expense Ratio | 1.82 | 2.39 |
| Manager | Sailesh Raj Bhan | Sanjeev Sharma |
| ISIN Code | INF204K01968 | INF966L01CG3 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Month | 2.16% | 1.13% |
| 6 Month | 3.03% | 5.13% |
| 1 Year | -0.53% | -6.29% |
| 3 Year | 20.87% | - |
| 5 Year | 18.19% | - |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 6 Month | -1.64% | -0.29% |
| 1 Year | 0.85% | 3.37% |
| 3 Year | 16.65% | - |
| 5 Year | 15.98% | - |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Year | 16.99% | 11.19% |
| 3 Year | 20.8% | - |
| 5 Year | 20.54% | - |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Standard Deviation | 15.24% | - |
| Sharp | 0.90% | - |
| Beta | 0.91% | - |
| Alpha | -0.55% | - |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Sanjeev Sharma |
| Total AUM | ₹96086 Cr | ₹39731 Cr |
| Funds Managed | 5 | 22 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Quant Healthcare Fund Regular - Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 1.52 | 32.28 |
| Large Cap | 33.27 | 9.19 |
| Mid Cap | 33.86 | 9.09 |
| Small Cap | 31.35 | 49.44 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 0.53 | 17.84 |
| Healthcare | 99.47 | 68.48 |
| Consumer Defensive | - | 7.74 |
| Financial Services | - | 5.94 |
Top Comparisons
SBI Midcap Fund - Regular Plan - Growth
3Y Returns16.28%
Invesco India Midcap Fund - Growth Option
3Y Returns27.26%
Tata Flexi Cap Fund -Regular Plan-Growth
3Y Returns16.03%
360 ONE FlexiCap Fund Regular - Growth
3Y Returns0%
Kotak Gilt-Investment Regular-Growth
3Y Returns6.25%
Kotak Gilt-Investment Regular-Growth
3Y Returns6.25%
Edelweiss Aggressive Hybrid Fund - Regular Plan - Growth Option
3Y Returns16.95%
HSBC Aggressive Hybrid Fund - Regular Growth
3Y Returns15.62%